ES2105617T3 - Derivados de piperacina como antagonistas de 5-ht. - Google Patents
Derivados de piperacina como antagonistas de 5-ht.Info
- Publication number
- ES2105617T3 ES2105617T3 ES94902964T ES94902964T ES2105617T3 ES 2105617 T3 ES2105617 T3 ES 2105617T3 ES 94902964 T ES94902964 T ES 94902964T ES 94902964 T ES94902964 T ES 94902964T ES 2105617 T3 ES2105617 T3 ES 2105617T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- derivatives
- date
- piperacine
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
LOS DERIVADOS DE LA PIPERACINA DE LA FORMULA (I) Y SUS SALES FARMACEUTICAMENTE ACEPTADAS SON AGENTES DE UNION 5-HT1 Y PUEDEN SER USADOS, POR EJEMPLO, COMO ANXIOLITICOS. EN LA FORMULA, R Y R3 SON HIDROGENO O ALQUILO BAJO O R3 ES ESPIROCICLOALQUILO, R1 Y R2 SON RADICALES DE ARIL O DE HETEREOARIL Y N ES 1 O 2 Y M ES DE 1 A 3 Y EL TOTAL DE N + M ES DE 2 - 4.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939300194A GB9300194D0 (en) | 1993-01-06 | 1993-01-06 | Piperazine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2105617T3 true ES2105617T3 (es) | 1997-10-16 |
Family
ID=10728386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94902964T Expired - Lifetime ES2105617T3 (es) | 1993-01-06 | 1993-12-24 | Derivados de piperacina como antagonistas de 5-ht. |
Country Status (13)
Country | Link |
---|---|
US (1) | US5622951A (es) |
EP (1) | EP0677046B1 (es) |
JP (1) | JPH08505381A (es) |
AT (1) | ATE155133T1 (es) |
AU (1) | AU5711594A (es) |
DE (1) | DE69312091T2 (es) |
DK (1) | DK0677046T3 (es) |
ES (1) | ES2105617T3 (es) |
GB (1) | GB9300194D0 (es) |
GR (1) | GR3024430T3 (es) |
IL (1) | IL108259A (es) |
PH (1) | PH31304A (es) |
WO (1) | WO1994015928A1 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5900415A (en) * | 1994-11-07 | 1999-05-04 | Pfizer Inc. | Certain substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligands |
US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
US6200994B1 (en) | 1999-01-07 | 2001-03-13 | American Home Products Corp | 1,4-Disubstituted cyclohexane derivatives for the treatment of depression |
DK1140919T3 (da) * | 1999-01-07 | 2002-12-30 | Wyeth Corp | 1,4-Disubstituerede cyclohexanderivater til behandling af depression |
US6313126B1 (en) | 1999-01-07 | 2001-11-06 | American Home Products Corp | Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
GB0316915D0 (en) | 2003-07-18 | 2003-08-20 | Glaxo Group Ltd | Compounds |
AR047759A1 (es) * | 2003-09-26 | 2006-02-22 | Vertex Pharma | Derivados de fenil - piperazina como moduladores de receptores muscarnicos |
JP4596792B2 (ja) * | 2004-02-24 | 2010-12-15 | あすか製薬株式会社 | 5−ht1a作動作用と5−ht3拮抗作用を併有する薬剤 |
EP1888523B1 (en) | 2005-06-03 | 2011-10-26 | Abbott Laboratories | Cyclobutyl amine derivatives |
US7576110B2 (en) | 2005-09-22 | 2009-08-18 | Abbott Laboratories | Benzothiazole cyclobutyl amine derivatives |
US9108948B2 (en) | 2006-06-23 | 2015-08-18 | Abbvie Inc. | Cyclopropyl amine derivatives |
AU2007260836B2 (en) | 2006-06-23 | 2012-11-15 | Abbvie Bahamas Ltd. | Cyclopropyl amine derivatives as histamin H3 receptor modulators |
US9186353B2 (en) | 2009-04-27 | 2015-11-17 | Abbvie Inc. | Treatment of osteoarthritis pain |
GB201017345D0 (en) | 2010-10-14 | 2010-11-24 | Proximagen Ltd | Receptor antagonists |
HUE033114T2 (en) | 2011-11-18 | 2017-11-28 | Heptares Therapeutics Ltd | Muscarin M1 receptor agonists |
SG10201909188XA (en) | 2015-04-02 | 2019-11-28 | Proximagen Llc | Novel therapies for cancer |
GB201513743D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
US10259787B2 (en) | 2016-10-14 | 2019-04-16 | Heptares Therapeutics Limited | Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists |
GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3309370A (en) * | 1964-07-16 | 1967-03-14 | Miles Lab | Bicycloalkyl piperazine derivatives and process |
US3354161A (en) * | 1964-07-16 | 1967-11-21 | Miles Lab | 8alpha-(4-phenyl-1-piperazyl)-4alpha, 5, 6, 7, 8alpha-hexahydro-4h-1-benzopyrans and process |
NL7314672A (es) * | 1972-11-11 | 1974-05-14 | ||
UST100505I4 (en) * | 1980-03-17 | 1981-04-07 | Triazolo[4,3-a]pyridin-3(2H)-ones | |
US5047406A (en) * | 1989-12-06 | 1991-09-10 | Warner-Lambert Co. | Substituted cyclohexanols as central nervous system agents |
US4975445A (en) * | 1989-12-06 | 1990-12-04 | Warner-Lambert Company | Substituted cyclohexenes as central nervous system agents |
FR2689893A1 (fr) * | 1992-04-09 | 1993-10-15 | Rhone Poulenc Rorer Sa | Dérivés de diphényl-1,1 hydroxy-3 (sila)cyclopentane, leur préparation et les médicaments les contenant. |
-
1993
- 1993-01-06 GB GB939300194A patent/GB9300194D0/en active Pending
- 1993-12-24 AT AT94902964T patent/ATE155133T1/de not_active IP Right Cessation
- 1993-12-24 ES ES94902964T patent/ES2105617T3/es not_active Expired - Lifetime
- 1993-12-24 US US08/436,413 patent/US5622951A/en not_active Expired - Lifetime
- 1993-12-24 JP JP6515782A patent/JPH08505381A/ja active Pending
- 1993-12-24 EP EP94902964A patent/EP0677046B1/en not_active Expired - Lifetime
- 1993-12-24 DE DE69312091T patent/DE69312091T2/de not_active Expired - Fee Related
- 1993-12-24 WO PCT/GB1993/002661 patent/WO1994015928A1/en active IP Right Grant
- 1993-12-24 AU AU57115/94A patent/AU5711594A/en not_active Abandoned
- 1993-12-24 DK DK94902964.9T patent/DK0677046T3/da active
-
1994
- 1994-01-03 IL IL10825994A patent/IL108259A/en not_active IP Right Cessation
- 1994-01-05 PH PH47581A patent/PH31304A/en unknown
-
1997
- 1997-08-13 GR GR970402073T patent/GR3024430T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US5622951A (en) | 1997-04-22 |
DE69312091D1 (de) | 1997-08-14 |
GB9300194D0 (en) | 1993-03-03 |
IL108259A (en) | 1998-09-24 |
JPH08505381A (ja) | 1996-06-11 |
DK0677046T3 (da) | 1997-09-01 |
ATE155133T1 (de) | 1997-07-15 |
GR3024430T3 (en) | 1997-11-28 |
DE69312091T2 (de) | 1998-02-19 |
WO1994015928A1 (en) | 1994-07-21 |
PH31304A (en) | 1998-07-06 |
AU5711594A (en) | 1994-08-15 |
IL108259A0 (en) | 1994-04-12 |
EP0677046A1 (en) | 1995-10-18 |
EP0677046B1 (en) | 1997-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2105617T3 (es) | Derivados de piperacina como antagonistas de 5-ht. | |
ES2123756T3 (es) | Derivados de piperazina. | |
DE69431471D1 (de) | Amide derivate als 5-ht1a liganden | |
DE59304311D1 (de) | N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika | |
ATE163402T1 (de) | Substituierte ortho- ethenylphenylessigsäurederivate | |
KR970706280A (ko) | 5-HT1A 길항제로서의 비사이클릭 카복스아미드(Bicyclic carboxamides as 5-HT1 antagonists) | |
ES2128572T3 (es) | Utilizacion de los derivados de cefem como agentes antimetastaticos. | |
ATE203022T1 (de) | 4-(6-fluor-1,2-benzisoxazolyl)-1-piperidinyl- propoxy-chromen-4-on-derivate,ihre herstellung und ihre verwendung in der behandlung von psychosen, schizophrenie und angstzuständen | |
DE69403896D1 (de) | 4-amino-2-(hetero)aryl-butanamide verwenbar als 5-ht1a-antagonisten | |
FI955707A (fi) | Indolijohdannaiset steroidi-5alfa-reduktaasin inhibiittoreina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 677046 Country of ref document: ES |